electroCore (ECOR) Cash & Equivalents Growth (3y) (2020 - 2026)
Powered by 
Analysis
electroCore (ECOR) Cash & Equivalents Growth (3y) (2020 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 180.08 Bn | 174.48 Bn | 7.27 Bn | -13.31% |
| 2 | Intuitive Surgical | 127.86 Bn | 122.64 Bn | 1.96 Bn | -7.03% |
| 3 | Medtronic | 117.15 Bn | 108.33 Bn | 6.34 Bn | 8.09% |
| 4 | Stryker | 103.82 Bn | 100.34 Bn | 4.50 Bn | 34.27% |
| 5 | Boston Scientific | 63.24 Bn | 62.70 Bn | 3.85 Bn | 8.16% |
| 6 | Edwards Lifesciences | 49.76 Bn | 45.51 Bn | 1.35 Bn | 40.74% |
| 7 | Alcon | 32.95 Bn | 31.49 Bn | 1.68 Bn | 27.03% |
| 8 | Dexcom | 32.22 Bn | 30.27 Bn | 830.00 Mn | -2.57% |
| 9 | Steris | 20.71 Bn | 20.23 Bn | 684.20 Mn | 32.23% |
| 10 | electroCore | 86.61 Mn | 76.57 Mn | 8.18 Mn | 0.23% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 0.23% |
| Mar 31, 2026 | -25.62% |
| Dec 31, 2025 | -26.49% |
| Sep 30, 2025 | -28.67% |
| Jun 30, 2025 | -49.59% |
| Mar 31, 2025 | -49.81% |
| Dec 31, 2024 | -52.58% |
| Sep 30, 2024 | -49.38% |
| Jun 30, 2024 | -24.28% |
| Mar 31, 2024 | -4.69% |
| Dec 31, 2023 | 34.54% |
| Sep 30, 2023 | 52.00% |
| Jun 30, 2023 | -17.18% |
| Mar 31, 2023 | -8.65% |
| Dec 31, 2022 | 9.30% |
| Sep 30, 2022 | 48.96% |
| Jun 30, 2022 | 44.47% |
| Mar 31, 2022 | 62.58% |
| Dec 31, 2021 | 65.88% |
| Sep 30, 2021 | 13.10% |